title: Echocardiography and clozapine: Is current clinical practice inhibiting use of a potentially life-transforming therapy?
authors.forename: Gail
authors.initials: G
authors.lastname: Robinson
authors.forename: Steve
authors.initials: S
authors.lastname: Kisely
authors.forename: Dan
authors.initials: D
authors.lastname: Siskind
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Flanagan
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: Wheeler
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001315:Australia; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004363:Drug Utilization / Q000706:statistics & numerical data; D004452:Echocardiography / Q000191:economics / Q000706:statistics & numerical data*; D005260:Female; D017048:Health Care Costs; D006801:Humans; D008297:Male; D009205:Myocarditis / Q000139:chemically induced* / Q000000981:diagnostic imaging* / Q000453:epidemiology; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000639:trends; D018570:Risk Assessment; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D012720:Severity of Illness Index; D019564:Unnecessary Procedures
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine